Clin2
NCT05946577Possibly a fitRecruiting

Links tinnitus and hearing changes after head and neck cancer treatment

Head CancerNeck Cancer

Part of Brain & nervous system, Cancer, Ear, nose & throat, Injuries & trauma, Mouth & dental clinical trials.

This study looks at how tinnitus (ringing in the ears) and hearing problems may develop after radiotherapy alone or with certain chemotherapy for high-risk head and neck cancer. The goal is to better understand who is more likely to experience these side effects.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
140 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are an adult (18 or older) with certain high-risk throat/ear/nose (ENT) cancer before or after surgery
  • You have not had any prior chemotherapy or radiation treatment
  • Your planned treatment includes radiation doses of about 60–70 Gy over 6–7 weeks, with the exact plan matching the study’s options
  • You can be treated with the cisplatin schedule the study uses, or you have a reason you can’t take cisplatin (so you get the study’s alternative treatment options)
  • Your tinnitus is not already moderate or worse (it must be below grade 2 on the study’s scale)
  • You have no major memory/thinking problems that would make it hard to complete the study tests

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06490029Recruiting
Hearing loss from cancer treatment: a diagnosis study

This study looks at hearing problems caused by cancer treatments that can damage the ears or nervous system. It aims to better understand and diagnose these side effects to help patients.

Paris
NCT06957132Not yet recruiting
Hearing loss risk after childhood cancer

This study looks at why some people who survived cancer as children or young adults develop hearing loss. It will check their hearing and review their past cancer treatments to find risk factors, so that future patients can be monitored more closely.

Paris
NCT07259915Not yet recruiting
Predicting response to chemoradiotherapy for head and neck cancer

This study looks at whether certain imaging tests (like MRI, CT, and PET scans) can predict how well your head and neck cancer responds to a standard treatment of radiation plus the chemotherapy drug cisplatin. If you join, researchers will use your scans and treatment results to help personalize care for future patients.

Rouen
NCT03914378Recruiting
Study how radiation and cisplatin affect hearing in head and neck cancer

This study looks at how radiotherapy, and possibly cisplatin chemotherapy, affect hearing in people treated for head and neck cancer. It may help doctors better predict hearing side effects and plan hearing monitoring or prevention.

Manchester
NCT06551857Recruiting
How cancer treatments affect hearing and thinking

This study looks at how common cancer treatments (certain chemotherapies and radiation to the head and neck) affect hearing in noisy places, thinking skills, and quality of life related to hearing. It aims to understand and possibly reduce these side effects.

Turku, Southwest Finland
NCT06929468Not yet recruiting
Hearing and balance side effects of cisplatin in head and neck cancer

This study looks at how cisplatin chemotherapy affects hearing and balance in people with head and neck cancer. It compares patients who get cisplatin with those who only get radiation, to understand and possibly reduce these side effects.

Nuremberg, Bavaria

Hear when a new Head Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.